Wednesday, 10 February 2016

Andres Mejia of McKinsey & Co. - Biotechnology Innovation

Andres Mejia of McKinsey & Co. is an experienced international professional who enjoys learning and educating himself. When Andres Mejia isn’t working with clients like McKinsey & Co., he often takes interest in biotechnology. Biotechnology is a modern field of study with innovative breakthroughs that could change the world we live in. Some of these innovations include:

Andres Mejia Mckinsey
  • Gene Therapy – Biotechnology is innovating gene therapy treatments that allow medical professionals to insert genes into patients’ cells, replacing existing, defective genes. Though the field is young, it already presents great medical potential.
  • Nanomedicine – Biotechnology allows medical professionals to manipulate biostructures and molecules atomically. For example, the use of metallic lenses allows oncologists to use heat energy to target and destroy cancer cells, and it offers hope of increasingly-effective cancer treatments.
  • Drug Delivery – Biotechnology is leading to great advancements in drug delivery systems. These drug delivery systems use microscopic particles, also known as microspheres, have small holes just wide enough to deliver drugs to target areas. Technologies like these offer hope of new treatments for diseases like cancer.
  • Stem Cells – Biotechnology is opening the door for professionals who are studying the viability of growing stem cells in a laboratory environment. These professionals are then using the stem cells to grow new, healthy tissues that can be implanted in patients.
Andres Mejia McKinsey & Co. and others interested in biotechnology see the future of this thrilling field of study. With the increasing popularity of such studies, the world is seeing innovation at a rate faster than ever before.